Niki BioSolutions, Inc. NIKI
Set alert
1.69 USD -0.08 -4.52%
At close
1.97 +0.28 +16.49%
Pre-market · Nov 3, 4:43 AM ET
1.67 Day range 1.79
1.67 52-week range 17.20
- YTD
- -84.06%
- 1 year
- -88.26%
- Open
- 1.79
- Prev close
- 1.77
- Mkt cap
- 5.27M
- Vol
- 25.50K
- Avg vol
- 97.53K
- EPS
- -2.77
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.67
- High
- 1.79
2Y chart
Signals (88)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 11, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| RSI: Oversold | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
Newest 20 of 88.
Financials — quick view
NIKI Revenue — annual 0
NIKI Net income — annual -1.36M
NIKI EPS — annual -1.90
News
- New York State Department Of Health Provides Clinical Laboratory Evaluation Program Test Approval To Niki BioSolutions' DiamiR Biosciences Subsidiary For Its APOE Genotyping Test
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Niki BioSolutions' DiamiR Biosciences Subsidiary To Perform Apolipoprotein E Genotyping On Plasma Samples From Global Alzheimer’s Platform Foundation Bio-Hermes-002 Trial Group
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Niki BioSolutions Enters At The Market Offering Agreement On October 9, 2026; May Sell Common Stock Up To $1.40M Aggregate Maximum Offering Price
Your note
Sign in to keep a note on NIKI — it syncs with the Stock Master app.
